GlaxoSmithKline (CAI:BIOC) General and Admin. Expense: E£64 Mil (TTM As of Sep. 2016)


What is GlaxoSmithKline General and Admin. Expense?

GlaxoSmithKline CAI:BIOC +0.49% General and Admin. Expense is E£64 Mil as of Sep. 2016.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. GlaxoSmithKline's General and Admin. Expense for the three months ended in Sep. 2016 was E£25 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2016 was E£64 Mil.

GlaxoSmithKline General and Admin. Expense Related Terms

GlaxoSmithKline General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline General and Admin. Expense Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
General and Admin. Expense
54.46 58.94 58.86 49.93

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.34 10.98 12.16 15.81 24.66

GlaxoSmithKline General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was E£64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of E£64 Mil mean?
GlaxoSmithKline (CAI:BIOC) has a General and Admin. Expense of E£64 Mil as of Sep. 2016. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's General and Admin. Expense too high?
GlaxoSmithKline's current General and Admin. Expense is E£64 Mil.
How does GlaxoSmithKline's General and Admin. Expense compare to PRPH?
GlaxoSmithKline's General and Admin. Expense of E£64 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on GlaxoSmithKline and its competitors. GlaxoSmithKline's current General and Admin. Expense is E£64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current General and Admin. Expense of E£64 Mil. The current General and Admin. Expense is E£64 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current General and Admin. Expense is E£64 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.